nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—ABCB1—hematologic cancer	0.085	1	CbGaD
Clopidogrel—CES1—Irinotecan—hematologic cancer	0.0353	0.0598	CbGbCtD
Clopidogrel—CYP1A2—Anagrelide—hematologic cancer	0.0205	0.0346	CbGbCtD
Clopidogrel—CYP2B6—Thiotepa—hematologic cancer	0.02	0.0339	CbGbCtD
Clopidogrel—CYP2C9—Bexarotene—hematologic cancer	0.0128	0.0216	CbGbCtD
Clopidogrel—ABCB1—Lenalidomide—hematologic cancer	0.0124	0.021	CbGbCtD
Clopidogrel—CYP2B6—Ifosfamide—hematologic cancer	0.0114	0.0192	CbGbCtD
Clopidogrel—CYP2C8—Bortezomib—hematologic cancer	0.0112	0.019	CbGbCtD
Clopidogrel—CYP3A5—Daunorubicin—hematologic cancer	0.0112	0.0189	CbGbCtD
Clopidogrel—CYP1A2—Carmustine—hematologic cancer	0.0107	0.0182	CbGbCtD
Clopidogrel—CYP2C9—Idarubicin—hematologic cancer	0.0106	0.0179	CbGbCtD
Clopidogrel—CYP3A5—Thalidomide—hematologic cancer	0.0102	0.0172	CbGbCtD
Clopidogrel—CYP2B6—Nilotinib—hematologic cancer	0.00987	0.0167	CbGbCtD
Clopidogrel—CYP3A5—Teniposide—hematologic cancer	0.00971	0.0164	CbGbCtD
Clopidogrel—CYP2C19—Bortezomib—hematologic cancer	0.00942	0.0159	CbGbCtD
Clopidogrel—CYP1A2—Methoxsalen—hematologic cancer	0.00914	0.0155	CbGbCtD
Clopidogrel—CYP3A5—Ifosfamide—hematologic cancer	0.00896	0.0152	CbGbCtD
Clopidogrel—CYP1A2—Bortezomib—hematologic cancer	0.00869	0.0147	CbGbCtD
Clopidogrel—CYP2C8—Ifosfamide—hematologic cancer	0.00861	0.0146	CbGbCtD
Clopidogrel—CYP3A5—Imatinib—hematologic cancer	0.00856	0.0145	CbGbCtD
Clopidogrel—CYP1A2—Daunorubicin—hematologic cancer	0.00831	0.0141	CbGbCtD
Clopidogrel—CYP2C19—Thalidomide—hematologic cancer	0.00821	0.0139	CbGbCtD
Clopidogrel—CYP1A2—Alitretinoin—hematologic cancer	0.00814	0.0138	CbGbCtD
Clopidogrel—CYP2C9—Bortezomib—hematologic cancer	0.00783	0.0133	CbGbCtD
Clopidogrel—CYP2C19—Teniposide—hematologic cancer	0.00783	0.0133	CbGbCtD
Clopidogrel—CYP1A2—Thalidomide—hematologic cancer	0.00757	0.0128	CbGbCtD
Clopidogrel—CYP2C8—Nilotinib—hematologic cancer	0.00748	0.0127	CbGbCtD
Clopidogrel—CYP3A4—Bexarotene—hematologic cancer	0.00743	0.0126	CbGbCtD
Clopidogrel—ABCB1—Daunorubicin—hematologic cancer	0.00727	0.0123	CbGbCtD
Clopidogrel—CYP2C19—Ifosfamide—hematologic cancer	0.00722	0.0122	CbGbCtD
Clopidogrel—ABCB1—Alitretinoin—hematologic cancer	0.00712	0.0121	CbGbCtD
Clopidogrel—CYP3A4—Busulfan—hematologic cancer	0.00691	0.0117	CbGbCtD
Clopidogrel—CYP3A4—Lomustine—hematologic cancer	0.00691	0.0117	CbGbCtD
Clopidogrel—CYP2C19—Imatinib—hematologic cancer	0.0069	0.0117	CbGbCtD
Clopidogrel—CYP3A5—Dasatinib—hematologic cancer	0.00687	0.0116	CbGbCtD
Clopidogrel—CYP2C9—Thalidomide—hematologic cancer	0.00682	0.0115	CbGbCtD
Clopidogrel—CYP2B6—Irinotecan—hematologic cancer	0.00678	0.0115	CbGbCtD
Clopidogrel—CYP1A2—Dacarbazine—hematologic cancer	0.00651	0.011	CbGbCtD
Clopidogrel—CYP2C9—Teniposide—hematologic cancer	0.00651	0.011	CbGbCtD
Clopidogrel—CYP1A2—Imatinib—hematologic cancer	0.00637	0.0108	CbGbCtD
Clopidogrel—CYP3A4—Thiotepa—hematologic cancer	0.00616	0.0104	CbGbCtD
Clopidogrel—CYP2C9—Ifosfamide—hematologic cancer	0.00601	0.0102	CbGbCtD
Clopidogrel—CYP2C9—Imatinib—hematologic cancer	0.00574	0.00971	CbGbCtD
Clopidogrel—ABCB1—Imatinib—hematologic cancer	0.00557	0.00943	CbGbCtD
Clopidogrel—CYP2B6—Cisplatin—hematologic cancer	0.00553	0.00936	CbGbCtD
Clopidogrel—CYP3A5—Irinotecan—hematologic cancer	0.00534	0.00905	CbGbCtD
Clopidogrel—CYP2C9—Nilotinib—hematologic cancer	0.00521	0.00883	CbGbCtD
Clopidogrel—CYP1A2—Dasatinib—hematologic cancer	0.00511	0.00866	CbGbCtD
Clopidogrel—ABCB1—Nilotinib—hematologic cancer	0.00506	0.00857	CbGbCtD
Clopidogrel—ABCB1—Vinorelbine—hematologic cancer	0.00502	0.00849	CbGbCtD
Clopidogrel—CYP3A4—Methoxsalen—hematologic cancer	0.00479	0.0081	CbGbCtD
Clopidogrel—CYP3A5—Vincristine—hematologic cancer	0.00467	0.00791	CbGbCtD
Clopidogrel—CYP3A4—Bortezomib—hematologic cancer	0.00455	0.00771	CbGbCtD
Clopidogrel—CYP2C19—Prednisone—hematologic cancer	0.00455	0.0077	CbGbCtD
Clopidogrel—ABCB1—Dasatinib—hematologic cancer	0.00447	0.00757	CbGbCtD
Clopidogrel—CYP2B6—Dexamethasone—hematologic cancer	0.00447	0.00756	CbGbCtD
Clopidogrel—ABCB1—Mitoxantrone—hematologic cancer	0.00442	0.00748	CbGbCtD
Clopidogrel—CYP3A4—Daunorubicin—hematologic cancer	0.00436	0.00737	CbGbCtD
Clopidogrel—CYP3A5—Etoposide—hematologic cancer	0.00428	0.00725	CbGbCtD
Clopidogrel—CYP2C8—Etoposide—hematologic cancer	0.00412	0.00697	CbGbCtD
Clopidogrel—ABCB1—Betamethasone—hematologic cancer	0.00394	0.00666	CbGbCtD
Clopidogrel—ABCB1—Gemcitabine—hematologic cancer	0.0039	0.00661	CbGbCtD
Clopidogrel—ABCB1—Prednisolone—hematologic cancer	0.00389	0.00658	CbGbCtD
Clopidogrel—CYP3A4—Cytarabine—hematologic cancer	0.00384	0.0065	CbGbCtD
Clopidogrel—CYP3A4—Teniposide—hematologic cancer	0.00378	0.00641	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—hematologic cancer	0.00371	0.00627	CbGbCtD
Clopidogrel—ABCB1—Prednisone—hematologic cancer	0.00367	0.00621	CbGbCtD
Clopidogrel—CYP3A5—Dexamethasone—hematologic cancer	0.00352	0.00596	CbGbCtD
Clopidogrel—CYP3A4—Ifosfamide—hematologic cancer	0.00349	0.00591	CbGbCtD
Clopidogrel—ABCB1—Irinotecan—hematologic cancer	0.00348	0.00589	CbGbCtD
Clopidogrel—CYP2C8—Dexamethasone—hematologic cancer	0.00338	0.00573	CbGbCtD
Clopidogrel—CYP3A4—Imatinib—hematologic cancer	0.00334	0.00565	CbGbCtD
Clopidogrel—CYP1A2—Etoposide—hematologic cancer	0.00319	0.00539	CbGbCtD
Clopidogrel—CYP3A4—Ruxolitinib—hematologic cancer	0.00314	0.00532	CbGbCtD
Clopidogrel—ABCB1—Vinblastine—hematologic cancer	0.00309	0.00523	CbGbCtD
Clopidogrel—ABCB1—Vincristine—hematologic cancer	0.00304	0.00515	CbGbCtD
Clopidogrel—CYP3A4—Nilotinib—hematologic cancer	0.00303	0.00513	CbGbCtD
Clopidogrel—CYP3A4—Vinorelbine—hematologic cancer	0.00301	0.00509	CbGbCtD
Clopidogrel—CYP2C9—Cisplatin—hematologic cancer	0.00292	0.00495	CbGbCtD
Clopidogrel—CYP2C19—Dexamethasone—hematologic cancer	0.00284	0.0048	CbGbCtD
Clopidogrel—ABCB1—Cisplatin—hematologic cancer	0.00284	0.0048	CbGbCtD
Clopidogrel—ABCB1—Etoposide—hematologic cancer	0.00279	0.00472	CbGbCtD
Clopidogrel—CYP3A4—Triamcinolone—hematologic cancer	0.00275	0.00465	CbGbCtD
Clopidogrel—CYP3A4—Dasatinib—hematologic cancer	0.00268	0.00454	CbGbCtD
Clopidogrel—CYP3A4—Mitoxantrone—hematologic cancer	0.00265	0.00448	CbGbCtD
Clopidogrel—P2RY12—hematopoietic system—hematologic cancer	0.00262	0.133	CbGeAlD
Clopidogrel—CYP2C9—Dexamethasone—hematologic cancer	0.00236	0.00399	CbGbCtD
Clopidogrel—CYP3A4—Betamethasone—hematologic cancer	0.00236	0.00399	CbGbCtD
Clopidogrel—CYP3A4—Prednisolone—hematologic cancer	0.00233	0.00394	CbGbCtD
Clopidogrel—ABCB1—Dexamethasone—hematologic cancer	0.00229	0.00388	CbGbCtD
Clopidogrel—CYP3A4—Prednisone—hematologic cancer	0.0022	0.00372	CbGbCtD
Clopidogrel—CYP3A4—Irinotecan—hematologic cancer	0.00208	0.00353	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—hematologic cancer	0.0019	0.00322	CbGbCtD
Clopidogrel—CYP3A4—Vinblastine—hematologic cancer	0.00185	0.00314	CbGbCtD
Clopidogrel—ABCB1—Methotrexate—hematologic cancer	0.00184	0.00312	CbGbCtD
Clopidogrel—CYP3A4—Vincristine—hematologic cancer	0.00182	0.00308	CbGbCtD
Clopidogrel—P2RY12—blood—hematologic cancer	0.00173	0.0883	CbGeAlD
Clopidogrel—CYP3A4—Etoposide—hematologic cancer	0.00167	0.00283	CbGbCtD
Clopidogrel—Ticlopidine—MPO—hematologic cancer	0.00162	0.714	CrCbGaD
Clopidogrel—CES1—hematopoietic system—hematologic cancer	0.00137	0.07	CbGeAlD
Clopidogrel—CYP3A4—Dexamethasone—hematologic cancer	0.00137	0.00232	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—hematologic cancer	0.00114	0.00193	CbGbCtD
Clopidogrel—CES1—blood—hematologic cancer	0.000911	0.0464	CbGeAlD
Clopidogrel—CES1—lung—hematologic cancer	0.000798	0.0407	CbGeAlD
Clopidogrel—CYP2C19—hematopoietic system—hematologic cancer	0.000769	0.0392	CbGeAlD
Clopidogrel—CES1—testis—hematologic cancer	0.000753	0.0384	CbGeAlD
Clopidogrel—CYP2C8—hematopoietic system—hematologic cancer	0.000672	0.0342	CbGeAlD
Clopidogrel—Prasugrel—ALB—hematologic cancer	0.000647	0.286	CrCbGaD
Clopidogrel—CYP1A2—hematopoietic system—hematologic cancer	0.000628	0.032	CbGeAlD
Clopidogrel—CYP3A5—hematopoietic system—hematologic cancer	0.000606	0.0309	CbGeAlD
Clopidogrel—CYP2B6—hematopoietic system—hematologic cancer	0.000602	0.0307	CbGeAlD
Clopidogrel—CYP2C9—hematopoietic system—hematologic cancer	0.000597	0.0304	CbGeAlD
Clopidogrel—CES1—lymph node—hematologic cancer	0.000546	0.0278	CbGeAlD
Clopidogrel—CYP2C19—blood—hematologic cancer	0.00051	0.026	CbGeAlD
Clopidogrel—CYP2B6—gonad—hematologic cancer	0.000458	0.0233	CbGeAlD
Clopidogrel—CYP3A4—hematopoietic system—hematologic cancer	0.000455	0.0232	CbGeAlD
Clopidogrel—CYP2C8—blood—hematologic cancer	0.000445	0.0227	CbGeAlD
Clopidogrel—CYP1A2—blood—hematologic cancer	0.000416	0.0212	CbGeAlD
Clopidogrel—CYP3A5—blood—hematologic cancer	0.000402	0.0205	CbGeAlD
Clopidogrel—CYP2B6—blood—hematologic cancer	0.000399	0.0203	CbGeAlD
Clopidogrel—CYP2C9—blood—hematologic cancer	0.000395	0.0201	CbGeAlD
Clopidogrel—CYP2C8—testis—hematologic cancer	0.000368	0.0187	CbGeAlD
Clopidogrel—CYP1A2—lung—hematologic cancer	0.000365	0.0186	CbGeAlD
Clopidogrel—CYP3A5—lung—hematologic cancer	0.000352	0.0179	CbGeAlD
Clopidogrel—CYP2B6—lung—hematologic cancer	0.00035	0.0178	CbGeAlD
Clopidogrel—CYP2B6—testis—hematologic cancer	0.00033	0.0168	CbGeAlD
Clopidogrel—ABCB1—hematopoietic system—hematologic cancer	0.000322	0.0164	CbGeAlD
Clopidogrel—CYP3A4—blood—hematologic cancer	0.000301	0.0153	CbGeAlD
Clopidogrel—ABCB1—gonad—hematologic cancer	0.000245	0.0125	CbGeAlD
Clopidogrel—ABCB1—blood—hematologic cancer	0.000213	0.0109	CbGeAlD
Clopidogrel—ABCB1—bone marrow—hematologic cancer	0.000206	0.0105	CbGeAlD
Clopidogrel—ABCB1—lung—hematologic cancer	0.000187	0.00952	CbGeAlD
Clopidogrel—ABCB1—testis—hematologic cancer	0.000176	0.00899	CbGeAlD
Clopidogrel—ABCB1—lymph node—hematologic cancer	0.000128	0.00651	CbGeAlD
Clopidogrel—Haemorrhage—Doxorubicin—hematologic cancer	1.85e-05	7.68e-05	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—hematologic cancer	1.85e-05	7.68e-05	CcSEcCtD
Clopidogrel—Hypersensitivity—Prednisolone—hematologic cancer	1.84e-05	7.65e-05	CcSEcCtD
Clopidogrel—Hypoaesthesia—Doxorubicin—hematologic cancer	1.84e-05	7.64e-05	CcSEcCtD
Clopidogrel—Dyspepsia—Betamethasone—hematologic cancer	1.83e-05	7.62e-05	CcSEcCtD
Clopidogrel—Dyspepsia—Dexamethasone—hematologic cancer	1.83e-05	7.62e-05	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—hematologic cancer	1.82e-05	7.59e-05	CcSEcCtD
Clopidogrel—Urticaria—Triamcinolone—hematologic cancer	1.82e-05	7.58e-05	CcSEcCtD
Clopidogrel—Oedema peripheral—Doxorubicin—hematologic cancer	1.82e-05	7.57e-05	CcSEcCtD
Clopidogrel—Asthenia—Etoposide—hematologic cancer	1.82e-05	7.55e-05	CcSEcCtD
Clopidogrel—Body temperature increased—Triamcinolone—hematologic cancer	1.81e-05	7.55e-05	CcSEcCtD
Clopidogrel—Oedema—Prednisone—hematologic cancer	1.81e-05	7.54e-05	CcSEcCtD
Clopidogrel—Anaphylactic shock—Prednisone—hematologic cancer	1.81e-05	7.54e-05	CcSEcCtD
Clopidogrel—Angiopathy—Epirubicin—hematologic cancer	1.81e-05	7.53e-05	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—hematologic cancer	1.81e-05	7.53e-05	CcSEcCtD
Clopidogrel—Nausea—Irinotecan—hematologic cancer	1.81e-05	7.52e-05	CcSEcCtD
Clopidogrel—Nausea—Mitoxantrone—hematologic cancer	1.81e-05	7.52e-05	CcSEcCtD
Clopidogrel—Immune system disorder—Epirubicin—hematologic cancer	1.8e-05	7.5e-05	CcSEcCtD
Clopidogrel—Infection—Prednisone—hematologic cancer	1.8e-05	7.49e-05	CcSEcCtD
Clopidogrel—Mediastinal disorder—Epirubicin—hematologic cancer	1.8e-05	7.48e-05	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.8e-05	7.48e-05	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.8e-05	7.48e-05	CcSEcCtD
Clopidogrel—Back pain—Methotrexate—hematologic cancer	1.8e-05	7.47e-05	CcSEcCtD
Clopidogrel—Fatigue—Dexamethasone—hematologic cancer	1.8e-05	7.47e-05	CcSEcCtD
Clopidogrel—Fatigue—Betamethasone—hematologic cancer	1.8e-05	7.47e-05	CcSEcCtD
Clopidogrel—Pruritus—Etoposide—hematologic cancer	1.79e-05	7.45e-05	CcSEcCtD
Clopidogrel—Shock—Prednisone—hematologic cancer	1.78e-05	7.42e-05	CcSEcCtD
Clopidogrel—Pain—Dexamethasone—hematologic cancer	1.78e-05	7.41e-05	CcSEcCtD
Clopidogrel—Pain—Betamethasone—hematologic cancer	1.78e-05	7.41e-05	CcSEcCtD
Clopidogrel—Visual impairment—Doxorubicin—hematologic cancer	1.78e-05	7.4e-05	CcSEcCtD
Clopidogrel—Nervous system disorder—Prednisone—hematologic cancer	1.78e-05	7.4e-05	CcSEcCtD
Clopidogrel—Skin disorder—Prednisone—hematologic cancer	1.76e-05	7.33e-05	CcSEcCtD
Clopidogrel—Nausea—Gemcitabine—hematologic cancer	1.76e-05	7.32e-05	CcSEcCtD
Clopidogrel—Vomiting—Cisplatin—hematologic cancer	1.76e-05	7.3e-05	CcSEcCtD
Clopidogrel—Mental disorder—Epirubicin—hematologic cancer	1.75e-05	7.28e-05	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—hematologic cancer	1.75e-05	7.26e-05	CcSEcCtD
Clopidogrel—Rash—Cisplatin—hematologic cancer	1.74e-05	7.24e-05	CcSEcCtD
Clopidogrel—Dermatitis—Cisplatin—hematologic cancer	1.74e-05	7.24e-05	CcSEcCtD
Clopidogrel—Malnutrition—Epirubicin—hematologic cancer	1.74e-05	7.23e-05	CcSEcCtD
Clopidogrel—Diarrhoea—Etoposide—hematologic cancer	1.73e-05	7.2e-05	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—hematologic cancer	1.73e-05	7.18e-05	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—hematologic cancer	1.72e-05	7.16e-05	CcSEcCtD
Clopidogrel—Anaemia—Methotrexate—hematologic cancer	1.72e-05	7.14e-05	CcSEcCtD
Clopidogrel—Feeling abnormal—Betamethasone—hematologic cancer	1.72e-05	7.14e-05	CcSEcCtD
Clopidogrel—Feeling abnormal—Dexamethasone—hematologic cancer	1.72e-05	7.14e-05	CcSEcCtD
Clopidogrel—Flatulence—Epirubicin—hematologic cancer	1.71e-05	7.12e-05	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.7e-05	7.08e-05	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Betamethasone—hematologic cancer	1.7e-05	7.08e-05	CcSEcCtD
Clopidogrel—Hypersensitivity—Triamcinolone—hematologic cancer	1.69e-05	7.03e-05	CcSEcCtD
Clopidogrel—Back pain—Epirubicin—hematologic cancer	1.68e-05	6.99e-05	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—hematologic cancer	1.68e-05	6.97e-05	CcSEcCtD
Clopidogrel—Dizziness—Etoposide—hematologic cancer	1.67e-05	6.96e-05	CcSEcCtD
Clopidogrel—Muscle spasms—Epirubicin—hematologic cancer	1.67e-05	6.95e-05	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—hematologic cancer	1.67e-05	6.94e-05	CcSEcCtD
Clopidogrel—Vertigo—Methotrexate—hematologic cancer	1.67e-05	6.94e-05	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—hematologic cancer	1.67e-05	6.92e-05	CcSEcCtD
Clopidogrel—Leukopenia—Methotrexate—hematologic cancer	1.66e-05	6.91e-05	CcSEcCtD
Clopidogrel—Urticaria—Betamethasone—hematologic cancer	1.65e-05	6.88e-05	CcSEcCtD
Clopidogrel—Urticaria—Dexamethasone—hematologic cancer	1.65e-05	6.88e-05	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.65e-05	6.87e-05	CcSEcCtD
Clopidogrel—Dizziness—Prednisolone—hematologic cancer	1.65e-05	6.86e-05	CcSEcCtD
Clopidogrel—Asthenia—Triamcinolone—hematologic cancer	1.65e-05	6.85e-05	CcSEcCtD
Clopidogrel—Abdominal pain—Dexamethasone—hematologic cancer	1.65e-05	6.85e-05	CcSEcCtD
Clopidogrel—Body temperature increased—Dexamethasone—hematologic cancer	1.65e-05	6.85e-05	CcSEcCtD
Clopidogrel—Abdominal pain—Betamethasone—hematologic cancer	1.65e-05	6.85e-05	CcSEcCtD
Clopidogrel—Body temperature increased—Betamethasone—hematologic cancer	1.65e-05	6.85e-05	CcSEcCtD
Clopidogrel—Nausea—Cisplatin—hematologic cancer	1.64e-05	6.82e-05	CcSEcCtD
Clopidogrel—Insomnia—Prednisone—hematologic cancer	1.64e-05	6.82e-05	CcSEcCtD
Clopidogrel—Paraesthesia—Prednisone—hematologic cancer	1.63e-05	6.77e-05	CcSEcCtD
Clopidogrel—Pruritus—Triamcinolone—hematologic cancer	1.62e-05	6.75e-05	CcSEcCtD
Clopidogrel—Cough—Methotrexate—hematologic cancer	1.62e-05	6.74e-05	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—hematologic cancer	1.62e-05	6.73e-05	CcSEcCtD
Clopidogrel—Vomiting—Etoposide—hematologic cancer	1.61e-05	6.69e-05	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—hematologic cancer	1.61e-05	6.69e-05	CcSEcCtD
Clopidogrel—Anaemia—Epirubicin—hematologic cancer	1.61e-05	6.68e-05	CcSEcCtD
Clopidogrel—Dyspepsia—Prednisone—hematologic cancer	1.6e-05	6.64e-05	CcSEcCtD
Clopidogrel—Rash—Etoposide—hematologic cancer	1.6e-05	6.64e-05	CcSEcCtD
Clopidogrel—Dermatitis—Etoposide—hematologic cancer	1.59e-05	6.63e-05	CcSEcCtD
Clopidogrel—Headache—Etoposide—hematologic cancer	1.59e-05	6.59e-05	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—hematologic cancer	1.58e-05	6.59e-05	CcSEcCtD
Clopidogrel—Chest pain—Methotrexate—hematologic cancer	1.58e-05	6.58e-05	CcSEcCtD
Clopidogrel—Myalgia—Methotrexate—hematologic cancer	1.58e-05	6.58e-05	CcSEcCtD
Clopidogrel—Arthralgia—Methotrexate—hematologic cancer	1.58e-05	6.58e-05	CcSEcCtD
Clopidogrel—Rash—Prednisolone—hematologic cancer	1.57e-05	6.55e-05	CcSEcCtD
Clopidogrel—Dermatitis—Prednisolone—hematologic cancer	1.57e-05	6.54e-05	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.57e-05	6.53e-05	CcSEcCtD
Clopidogrel—Fatigue—Prednisone—hematologic cancer	1.56e-05	6.5e-05	CcSEcCtD
Clopidogrel—Headache—Prednisolone—hematologic cancer	1.56e-05	6.5e-05	CcSEcCtD
Clopidogrel—Vertigo—Epirubicin—hematologic cancer	1.56e-05	6.49e-05	CcSEcCtD
Clopidogrel—Syncope—Epirubicin—hematologic cancer	1.56e-05	6.48e-05	CcSEcCtD
Clopidogrel—Leukopenia—Epirubicin—hematologic cancer	1.56e-05	6.47e-05	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—hematologic cancer	1.56e-05	6.47e-05	CcSEcCtD
Clopidogrel—Constipation—Prednisone—hematologic cancer	1.55e-05	6.45e-05	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—hematologic cancer	1.55e-05	6.43e-05	CcSEcCtD
Clopidogrel—Palpitations—Epirubicin—hematologic cancer	1.54e-05	6.39e-05	CcSEcCtD
Clopidogrel—Confusional state—Methotrexate—hematologic cancer	1.53e-05	6.36e-05	CcSEcCtD
Clopidogrel—Loss of consciousness—Epirubicin—hematologic cancer	1.53e-05	6.35e-05	CcSEcCtD
Clopidogrel—Dizziness—Triamcinolone—hematologic cancer	1.52e-05	6.31e-05	CcSEcCtD
Clopidogrel—Cough—Epirubicin—hematologic cancer	1.52e-05	6.31e-05	CcSEcCtD
Clopidogrel—Anaphylactic shock—Methotrexate—hematologic cancer	1.52e-05	6.3e-05	CcSEcCtD
Clopidogrel—Infection—Methotrexate—hematologic cancer	1.51e-05	6.26e-05	CcSEcCtD
Clopidogrel—Nausea—Etoposide—hematologic cancer	1.5e-05	6.25e-05	CcSEcCtD
Clopidogrel—Hypertension—Epirubicin—hematologic cancer	1.5e-05	6.24e-05	CcSEcCtD
Clopidogrel—Feeling abnormal—Prednisone—hematologic cancer	1.49e-05	6.22e-05	CcSEcCtD
Clopidogrel—Asthenia—Betamethasone—hematologic cancer	1.49e-05	6.21e-05	CcSEcCtD
Clopidogrel—Asthenia—Dexamethasone—hematologic cancer	1.49e-05	6.21e-05	CcSEcCtD
Clopidogrel—Nervous system disorder—Methotrexate—hematologic cancer	1.49e-05	6.18e-05	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—hematologic cancer	1.49e-05	6.18e-05	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Prednisone—hematologic cancer	1.48e-05	6.17e-05	CcSEcCtD
Clopidogrel—Nausea—Prednisolone—hematologic cancer	1.48e-05	6.17e-05	CcSEcCtD
Clopidogrel—Chest pain—Epirubicin—hematologic cancer	1.48e-05	6.15e-05	CcSEcCtD
Clopidogrel—Arthralgia—Epirubicin—hematologic cancer	1.48e-05	6.15e-05	CcSEcCtD
Clopidogrel—Myalgia—Epirubicin—hematologic cancer	1.48e-05	6.15e-05	CcSEcCtD
Clopidogrel—Anxiety—Epirubicin—hematologic cancer	1.47e-05	6.13e-05	CcSEcCtD
Clopidogrel—Pruritus—Betamethasone—hematologic cancer	1.47e-05	6.13e-05	CcSEcCtD
Clopidogrel—Pruritus—Dexamethasone—hematologic cancer	1.47e-05	6.13e-05	CcSEcCtD
Clopidogrel—Skin disorder—Methotrexate—hematologic cancer	1.47e-05	6.12e-05	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.47e-05	6.11e-05	CcSEcCtD
Clopidogrel—Vomiting—Triamcinolone—hematologic cancer	1.46e-05	6.07e-05	CcSEcCtD
Clopidogrel—Rash—Triamcinolone—hematologic cancer	1.45e-05	6.02e-05	CcSEcCtD
Clopidogrel—Dermatitis—Triamcinolone—hematologic cancer	1.45e-05	6.01e-05	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—hematologic cancer	1.44e-05	6.01e-05	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—hematologic cancer	1.44e-05	6e-05	CcSEcCtD
Clopidogrel—Urticaria—Prednisone—hematologic cancer	1.44e-05	5.99e-05	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—hematologic cancer	1.44e-05	5.99e-05	CcSEcCtD
Clopidogrel—Headache—Triamcinolone—hematologic cancer	1.44e-05	5.98e-05	CcSEcCtD
Clopidogrel—Body temperature increased—Prednisone—hematologic cancer	1.43e-05	5.96e-05	CcSEcCtD
Clopidogrel—Abdominal pain—Prednisone—hematologic cancer	1.43e-05	5.96e-05	CcSEcCtD
Clopidogrel—Confusional state—Epirubicin—hematologic cancer	1.43e-05	5.95e-05	CcSEcCtD
Clopidogrel—Diarrhoea—Dexamethasone—hematologic cancer	1.43e-05	5.93e-05	CcSEcCtD
Clopidogrel—Diarrhoea—Betamethasone—hematologic cancer	1.43e-05	5.93e-05	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—hematologic cancer	1.42e-05	5.91e-05	CcSEcCtD
Clopidogrel—Oedema—Epirubicin—hematologic cancer	1.42e-05	5.9e-05	CcSEcCtD
Clopidogrel—Anaphylactic shock—Epirubicin—hematologic cancer	1.42e-05	5.9e-05	CcSEcCtD
Clopidogrel—Hypotension—Methotrexate—hematologic cancer	1.42e-05	5.89e-05	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—hematologic cancer	1.41e-05	5.88e-05	CcSEcCtD
Clopidogrel—Infection—Epirubicin—hematologic cancer	1.41e-05	5.86e-05	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—hematologic cancer	1.4e-05	5.84e-05	CcSEcCtD
Clopidogrel—Shock—Epirubicin—hematologic cancer	1.4e-05	5.8e-05	CcSEcCtD
Clopidogrel—Nervous system disorder—Epirubicin—hematologic cancer	1.39e-05	5.79e-05	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—hematologic cancer	1.39e-05	5.77e-05	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.38e-05	5.74e-05	CcSEcCtD
Clopidogrel—Skin disorder—Epirubicin—hematologic cancer	1.38e-05	5.73e-05	CcSEcCtD
Clopidogrel—Dizziness—Dexamethasone—hematologic cancer	1.38e-05	5.73e-05	CcSEcCtD
Clopidogrel—Dizziness—Betamethasone—hematologic cancer	1.38e-05	5.73e-05	CcSEcCtD
Clopidogrel—Insomnia—Methotrexate—hematologic cancer	1.37e-05	5.7e-05	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—hematologic cancer	1.37e-05	5.69e-05	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—hematologic cancer	1.37e-05	5.69e-05	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—hematologic cancer	1.37e-05	5.69e-05	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—hematologic cancer	1.36e-05	5.67e-05	CcSEcCtD
Clopidogrel—Nausea—Triamcinolone—hematologic cancer	1.36e-05	5.67e-05	CcSEcCtD
Clopidogrel—Paraesthesia—Methotrexate—hematologic cancer	1.36e-05	5.66e-05	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.36e-05	5.66e-05	CcSEcCtD
Clopidogrel—Dyspnoea—Methotrexate—hematologic cancer	1.35e-05	5.62e-05	CcSEcCtD
Clopidogrel—Hypersensitivity—Prednisone—hematologic cancer	1.34e-05	5.56e-05	CcSEcCtD
Clopidogrel—Dyspepsia—Methotrexate—hematologic cancer	1.33e-05	5.55e-05	CcSEcCtD
Clopidogrel—Hypotension—Epirubicin—hematologic cancer	1.33e-05	5.51e-05	CcSEcCtD
Clopidogrel—Vomiting—Dexamethasone—hematologic cancer	1.32e-05	5.51e-05	CcSEcCtD
Clopidogrel—Vomiting—Betamethasone—hematologic cancer	1.32e-05	5.51e-05	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—hematologic cancer	1.32e-05	5.5e-05	CcSEcCtD
Clopidogrel—Rash—Betamethasone—hematologic cancer	1.31e-05	5.46e-05	CcSEcCtD
Clopidogrel—Rash—Dexamethasone—hematologic cancer	1.31e-05	5.46e-05	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—hematologic cancer	1.31e-05	5.46e-05	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—hematologic cancer	1.31e-05	5.46e-05	CcSEcCtD
Clopidogrel—Dermatitis—Dexamethasone—hematologic cancer	1.31e-05	5.46e-05	CcSEcCtD
Clopidogrel—Dermatitis—Betamethasone—hematologic cancer	1.31e-05	5.46e-05	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.31e-05	5.44e-05	CcSEcCtD
Clopidogrel—Fatigue—Methotrexate—hematologic cancer	1.31e-05	5.44e-05	CcSEcCtD
Clopidogrel—Headache—Betamethasone—hematologic cancer	1.3e-05	5.43e-05	CcSEcCtD
Clopidogrel—Headache—Dexamethasone—hematologic cancer	1.3e-05	5.43e-05	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—hematologic cancer	1.3e-05	5.42e-05	CcSEcCtD
Clopidogrel—Asthenia—Prednisone—hematologic cancer	1.3e-05	5.41e-05	CcSEcCtD
Clopidogrel—Pain—Methotrexate—hematologic cancer	1.3e-05	5.39e-05	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.29e-05	5.37e-05	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—hematologic cancer	1.29e-05	5.37e-05	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—hematologic cancer	1.29e-05	5.35e-05	CcSEcCtD
Clopidogrel—Pruritus—Prednisone—hematologic cancer	1.28e-05	5.34e-05	CcSEcCtD
Clopidogrel—Insomnia—Epirubicin—hematologic cancer	1.28e-05	5.34e-05	CcSEcCtD
Clopidogrel—Skin disorder—Doxorubicin—hematologic cancer	1.27e-05	5.3e-05	CcSEcCtD
Clopidogrel—Paraesthesia—Epirubicin—hematologic cancer	1.27e-05	5.3e-05	CcSEcCtD
Clopidogrel—Dyspnoea—Epirubicin—hematologic cancer	1.26e-05	5.26e-05	CcSEcCtD
Clopidogrel—Feeling abnormal—Methotrexate—hematologic cancer	1.25e-05	5.19e-05	CcSEcCtD
Clopidogrel—Dyspepsia—Epirubicin—hematologic cancer	1.25e-05	5.19e-05	CcSEcCtD
Clopidogrel—Diarrhoea—Prednisone—hematologic cancer	1.24e-05	5.16e-05	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Methotrexate—hematologic cancer	1.24e-05	5.15e-05	CcSEcCtD
Clopidogrel—Nausea—Dexamethasone—hematologic cancer	1.24e-05	5.14e-05	CcSEcCtD
Clopidogrel—Nausea—Betamethasone—hematologic cancer	1.24e-05	5.14e-05	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—hematologic cancer	1.23e-05	5.1e-05	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.22e-05	5.09e-05	CcSEcCtD
Clopidogrel—Fatigue—Epirubicin—hematologic cancer	1.22e-05	5.09e-05	CcSEcCtD
Clopidogrel—Pain—Epirubicin—hematologic cancer	1.21e-05	5.04e-05	CcSEcCtD
Clopidogrel—Constipation—Epirubicin—hematologic cancer	1.21e-05	5.04e-05	CcSEcCtD
Clopidogrel—Urticaria—Methotrexate—hematologic cancer	1.2e-05	5.01e-05	CcSEcCtD
Clopidogrel—Dizziness—Prednisone—hematologic cancer	1.2e-05	4.99e-05	CcSEcCtD
Clopidogrel—Abdominal pain—Methotrexate—hematologic cancer	1.2e-05	4.98e-05	CcSEcCtD
Clopidogrel—Body temperature increased—Methotrexate—hematologic cancer	1.2e-05	4.98e-05	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.2e-05	4.97e-05	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—hematologic cancer	1.19e-05	4.94e-05	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—hematologic cancer	1.18e-05	4.9e-05	CcSEcCtD
Clopidogrel—Dyspnoea—Doxorubicin—hematologic cancer	1.17e-05	4.87e-05	CcSEcCtD
Clopidogrel—Feeling abnormal—Epirubicin—hematologic cancer	1.17e-05	4.86e-05	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Epirubicin—hematologic cancer	1.16e-05	4.82e-05	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—hematologic cancer	1.16e-05	4.81e-05	CcSEcCtD
Clopidogrel—Vomiting—Prednisone—hematologic cancer	1.15e-05	4.8e-05	CcSEcCtD
Clopidogrel—Rash—Prednisone—hematologic cancer	1.14e-05	4.76e-05	CcSEcCtD
Clopidogrel—Dermatitis—Prednisone—hematologic cancer	1.14e-05	4.75e-05	CcSEcCtD
Clopidogrel—Headache—Prednisone—hematologic cancer	1.14e-05	4.73e-05	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.13e-05	4.71e-05	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—hematologic cancer	1.13e-05	4.71e-05	CcSEcCtD
Clopidogrel—Urticaria—Epirubicin—hematologic cancer	1.13e-05	4.69e-05	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—hematologic cancer	1.12e-05	4.67e-05	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—hematologic cancer	1.12e-05	4.67e-05	CcSEcCtD
Clopidogrel—Abdominal pain—Epirubicin—hematologic cancer	1.12e-05	4.66e-05	CcSEcCtD
Clopidogrel—Body temperature increased—Epirubicin—hematologic cancer	1.12e-05	4.66e-05	CcSEcCtD
Clopidogrel—Hypersensitivity—Methotrexate—hematologic cancer	1.12e-05	4.64e-05	CcSEcCtD
Clopidogrel—Asthenia—Methotrexate—hematologic cancer	1.09e-05	4.52e-05	CcSEcCtD
Clopidogrel—Feeling abnormal—Doxorubicin—hematologic cancer	1.08e-05	4.5e-05	CcSEcCtD
Clopidogrel—Nausea—Prednisone—hematologic cancer	1.08e-05	4.48e-05	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.07e-05	4.46e-05	CcSEcCtD
Clopidogrel—Pruritus—Methotrexate—hematologic cancer	1.07e-05	4.46e-05	CcSEcCtD
Clopidogrel—Hypersensitivity—Epirubicin—hematologic cancer	1.05e-05	4.35e-05	CcSEcCtD
Clopidogrel—Urticaria—Doxorubicin—hematologic cancer	1.04e-05	4.34e-05	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—hematologic cancer	1.04e-05	4.32e-05	CcSEcCtD
Clopidogrel—Abdominal pain—Doxorubicin—hematologic cancer	1.04e-05	4.32e-05	CcSEcCtD
Clopidogrel—Diarrhoea—Methotrexate—hematologic cancer	1.04e-05	4.31e-05	CcSEcCtD
Clopidogrel—Asthenia—Epirubicin—hematologic cancer	1.02e-05	4.23e-05	CcSEcCtD
Clopidogrel—Pruritus—Epirubicin—hematologic cancer	1e-05	4.17e-05	CcSEcCtD
Clopidogrel—Dizziness—Methotrexate—hematologic cancer	1e-05	4.17e-05	CcSEcCtD
Clopidogrel—Diarrhoea—Epirubicin—hematologic cancer	9.71e-06	4.04e-05	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—hematologic cancer	9.67e-06	4.02e-05	CcSEcCtD
Clopidogrel—Vomiting—Methotrexate—hematologic cancer	9.64e-06	4.01e-05	CcSEcCtD
Clopidogrel—Rash—Methotrexate—hematologic cancer	9.56e-06	3.97e-05	CcSEcCtD
Clopidogrel—Dermatitis—Methotrexate—hematologic cancer	9.55e-06	3.97e-05	CcSEcCtD
Clopidogrel—Headache—Methotrexate—hematologic cancer	9.5e-06	3.95e-05	CcSEcCtD
Clopidogrel—Asthenia—Doxorubicin—hematologic cancer	9.42e-06	3.92e-05	CcSEcCtD
Clopidogrel—Dizziness—Epirubicin—hematologic cancer	9.38e-06	3.9e-05	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—hematologic cancer	9.29e-06	3.86e-05	CcSEcCtD
Clopidogrel—Vomiting—Epirubicin—hematologic cancer	9.02e-06	3.75e-05	CcSEcCtD
Clopidogrel—Nausea—Methotrexate—hematologic cancer	9e-06	3.74e-05	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—hematologic cancer	8.98e-06	3.73e-05	CcSEcCtD
Clopidogrel—Rash—Epirubicin—hematologic cancer	8.94e-06	3.72e-05	CcSEcCtD
Clopidogrel—Dermatitis—Epirubicin—hematologic cancer	8.94e-06	3.72e-05	CcSEcCtD
Clopidogrel—Headache—Epirubicin—hematologic cancer	8.89e-06	3.7e-05	CcSEcCtD
Clopidogrel—Dizziness—Doxorubicin—hematologic cancer	8.68e-06	3.61e-05	CcSEcCtD
Clopidogrel—Nausea—Epirubicin—hematologic cancer	8.43e-06	3.5e-05	CcSEcCtD
Clopidogrel—Vomiting—Doxorubicin—hematologic cancer	8.35e-06	3.47e-05	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—hematologic cancer	8.28e-06	3.44e-05	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—hematologic cancer	8.27e-06	3.44e-05	CcSEcCtD
Clopidogrel—Headache—Doxorubicin—hematologic cancer	8.22e-06	3.42e-05	CcSEcCtD
Clopidogrel—Nausea—Doxorubicin—hematologic cancer	7.8e-06	3.24e-05	CcSEcCtD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.31e-06	8.58e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ENO2—hematologic cancer	5.3e-06	8.57e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ABCG2—hematologic cancer	5.28e-06	8.53e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—MTR—hematologic cancer	5.28e-06	8.53e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYCS—hematologic cancer	5.23e-06	8.46e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—IDH1—hematologic cancer	5.23e-06	8.45e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NUP98—hematologic cancer	5.22e-06	8.44e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	5.2e-06	8.4e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ENO2—hematologic cancer	5.17e-06	8.37e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.17e-06	8.35e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—TXN—hematologic cancer	5.17e-06	8.35e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.17e-06	8.35e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MAPK3—hematologic cancer	5.16e-06	8.35e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTT1—hematologic cancer	5.14e-06	8.31e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.08e-06	8.21e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.07e-06	8.19e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.07e-06	8.19e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.06e-06	8.19e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.06e-06	8.17e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—FHL2—hematologic cancer	5.04e-06	8.16e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NUP214—hematologic cancer	5.03e-06	8.13e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SDC1—hematologic cancer	5.03e-06	8.13e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MYC—hematologic cancer	5.02e-06	8.12e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTT1—hematologic cancer	5.02e-06	8.11e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TGFB1—hematologic cancer	5.01e-06	8.1e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.98e-06	8.05e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—AGRN—hematologic cancer	4.95e-06	8e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—MTR—hematologic cancer	4.93e-06	7.97e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.93e-06	7.97e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SDC1—hematologic cancer	4.9e-06	7.93e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.87e-06	7.87e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.86e-06	7.85e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ENO2—hematologic cancer	4.83e-06	7.82e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.8e-06	7.76e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—NQO1—hematologic cancer	4.79e-06	7.74e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CD44—hematologic cancer	4.79e-06	7.74e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.74e-06	7.66e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.73e-06	7.64e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.73e-06	7.64e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTP1—hematologic cancer	4.72e-06	7.63e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.7e-06	7.6e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—HMMR—hematologic cancer	4.69e-06	7.58e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—IDH2—hematologic cancer	4.69e-06	7.58e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.69e-06	7.58e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.69e-06	7.58e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—KRAS—hematologic cancer	4.64e-06	7.5e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.62e-06	7.46e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.61e-06	7.45e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.61e-06	7.45e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SDC1—hematologic cancer	4.58e-06	7.41e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.53e-06	7.33e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYCS—hematologic cancer	4.53e-06	7.32e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.5e-06	7.28e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ABCB1—hematologic cancer	4.46e-06	7.22e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NUP98—hematologic cancer	4.46e-06	7.21e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.41e-06	7.13e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.4e-06	7.11e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.38e-06	7.08e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.36e-06	7.06e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—NCOR1—hematologic cancer	4.33e-06	7.01e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTM1—hematologic cancer	4.33e-06	7.01e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.33e-06	7e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.33e-06	7e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.32e-06	6.99e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NUP214—hematologic cancer	4.3e-06	6.95e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ACP5—hematologic cancer	4.29e-06	6.93e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CA9—hematologic cancer	4.29e-06	6.93e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CD44—hematologic cancer	4.27e-06	6.91e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—NQO1—hematologic cancer	4.27e-06	6.91e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CA—hematologic cancer	4.26e-06	6.89e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.25e-06	6.88e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.24e-06	6.85e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.24e-06	6.85e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.23e-06	6.84e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.21e-06	6.81e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—MTR—hematologic cancer	4.21e-06	6.81e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.18e-06	6.76e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—NQO1—hematologic cancer	4.17e-06	6.74e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CD44—hematologic cancer	4.17e-06	6.74e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.13e-06	6.68e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ENO2—hematologic cancer	4.13e-06	6.68e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—hematologic cancer	4.12e-06	6.67e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.05e-06	6.55e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYCS—hematologic cancer	4.04e-06	6.54e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—IDH1—hematologic cancer	4.03e-06	6.52e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	4.02e-06	6.5e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.01e-06	6.48e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.99e-06	6.46e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—TXN—hematologic cancer	3.99e-06	6.45e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.99e-06	6.45e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.99e-06	6.45e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYCS—hematologic cancer	3.95e-06	6.38e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.94e-06	6.38e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HRAS—hematologic cancer	3.94e-06	6.38e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.92e-06	6.34e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SDC1—hematologic cancer	3.92e-06	6.33e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.9e-06	6.31e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NQO1—hematologic cancer	3.9e-06	6.3e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CD44—hematologic cancer	3.9e-06	6.3e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.86e-06	6.25e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.83e-06	6.19e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.82e-06	6.17e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.78e-06	6.11e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL6—hematologic cancer	3.77e-06	6.1e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.75e-06	6.06e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.74e-06	6.05e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.74e-06	6.05e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.69e-06	5.97e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYCS—hematologic cancer	3.69e-06	5.96e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.67e-06	5.93e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.67e-06	5.93e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.66e-06	5.92e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.65e-06	5.9e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.65e-06	5.9e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.62e-06	5.85e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.56e-06	5.76e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.55e-06	5.75e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.53e-06	5.71e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—AKT1—hematologic cancer	3.48e-06	5.63e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTP1—hematologic cancer	3.48e-06	5.62e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.45e-06	5.57e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NUP98—hematologic cancer	3.44e-06	5.57e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.37e-06	5.45e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.34e-06	5.4e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.34e-06	5.4e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CD44—hematologic cancer	3.33e-06	5.38e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NQO1—hematologic cancer	3.33e-06	5.38e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NUP214—hematologic cancer	3.32e-06	5.36e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.3e-06	5.33e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.27e-06	5.3e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.27e-06	5.3e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.26e-06	5.27e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—MTR—hematologic cancer	3.25e-06	5.26e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.25e-06	5.26e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.25e-06	5.25e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.24e-06	5.24e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CG—hematologic cancer	3.22e-06	5.2e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—NCOR1—hematologic cancer	3.2e-06	5.17e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTM1—hematologic cancer	3.2e-06	5.17e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ENO2—hematologic cancer	3.19e-06	5.15e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYCS—hematologic cancer	3.15e-06	5.09e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.15e-06	5.09e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.14e-06	5.08e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.13e-06	5.06e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.09e-06	5e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.08e-06	4.97e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SDC1—hematologic cancer	3.02e-06	4.89e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.99e-06	4.83e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.99e-06	4.83e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.98e-06	4.82e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.92e-06	4.72e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.89e-06	4.68e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.86e-06	4.62e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.83e-06	4.57e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—MTHFR—hematologic cancer	2.82e-06	4.57e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.82e-06	4.55e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ALB—hematologic cancer	2.79e-06	4.52e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.78e-06	4.49e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.77e-06	4.47e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ALB—hematologic cancer	2.73e-06	4.41e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.72e-06	4.4e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.69e-06	4.34e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.67e-06	4.32e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.64e-06	4.27e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.63e-06	4.25e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.61e-06	4.22e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NQO1—hematologic cancer	2.57e-06	4.15e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CD44—hematologic cancer	2.57e-06	4.15e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.55e-06	4.13e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.55e-06	4.13e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.55e-06	4.12e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.53e-06	4.08e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.47e-06	3.99e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.43e-06	3.93e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYCS—hematologic cancer	2.43e-06	3.93e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.42e-06	3.91e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.41e-06	3.9e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.4e-06	3.87e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.37e-06	3.84e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ALB—hematologic cancer	2.36e-06	3.82e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.33e-06	3.76e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.26e-06	3.66e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.26e-06	3.65e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.25e-06	3.65e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.22e-06	3.59e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CREBBP—hematologic cancer	2.2e-06	3.56e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.14e-06	3.47e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.14e-06	3.46e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTEN—hematologic cancer	2.13e-06	3.45e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ALB—hematologic cancer	2.11e-06	3.41e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.09e-06	3.38e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.09e-06	3.37e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTEN—hematologic cancer	2.08e-06	3.37e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ALB—hematologic cancer	2.06e-06	3.33e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.06e-06	3.32e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—EP300—hematologic cancer	2.03e-06	3.29e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.03e-06	3.28e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.02e-06	3.26e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.99e-06	3.21e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—EP300—hematologic cancer	1.99e-06	3.21e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.97e-06	3.19e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.97e-06	3.18e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.97e-06	3.18e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.95e-06	3.15e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ALB—hematologic cancer	1.92e-06	3.11e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.89e-06	3.06e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.86e-06	3.01e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.84e-06	2.98e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.82e-06	2.94e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTEN—hematologic cancer	1.8e-06	2.92e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.76e-06	2.84e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.74e-06	2.81e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—EP300—hematologic cancer	1.72e-06	2.78e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.7e-06	2.75e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.67e-06	2.69e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ALB—hematologic cancer	1.64e-06	2.66e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTEN—hematologic cancer	1.61e-06	2.6e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.57e-06	2.54e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTEN—hematologic cancer	1.57e-06	2.54e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—EP300—hematologic cancer	1.54e-06	2.48e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.5e-06	2.43e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—EP300—hematologic cancer	1.5e-06	2.42e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.47e-06	2.38e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTEN—hematologic cancer	1.47e-06	2.37e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.46e-06	2.36e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.45e-06	2.35e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—EP300—hematologic cancer	1.4e-06	2.26e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.36e-06	2.19e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.29e-06	2.08e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.27e-06	2.06e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ALB—hematologic cancer	1.27e-06	2.05e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTEN—hematologic cancer	1.25e-06	2.03e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—AKT1—hematologic cancer	1.23e-06	1.99e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.21e-06	1.96e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—AKT1—hematologic cancer	1.2e-06	1.94e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—EP300—hematologic cancer	1.2e-06	1.93e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.14e-06	1.84e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.12e-06	1.81e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.11e-06	1.79e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—AKT1—hematologic cancer	1.04e-06	1.68e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.04e-06	1.67e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTEN—hematologic cancer	9.68e-07	1.57e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—AKT1—hematologic cancer	9.28e-07	1.5e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—EP300—hematologic cancer	9.23e-07	1.49e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—AKT1—hematologic cancer	9.06e-07	1.46e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CA—hematologic cancer	8.85e-07	1.43e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—AKT1—hematologic cancer	8.46e-07	1.37e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—AKT1—hematologic cancer	7.23e-07	1.17e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.83e-07	1.1e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—AKT1—hematologic cancer	5.58e-07	9.02e-06	CbGpPWpGaD
